Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- SELB +16.3%, SOL +11.2%, HPJ +8%, FNJN +5.8%, RHT +4.8%, DRI +4.2%, (also to acquire Cheddar's Scratch Kitchen for $780 mln in an all-cash transaction)
- WPRT +4.1%, (also details actions being taken to address upcoming liquidity needs), AKBA +4%, HOME +3.1%, GALT +3%, SNX +2.2%
- TRQ +1.6%, FBM +1.2%, SBS +0.9%
Other news:
- PSIX +53.9% (Weichai America will invest $60 mln in the co through a combination of newly issued common equity at $8.00/share and preferred shares)
- RXII +32.9% (granted a patent from the Japan Patent Office for the composition of matter of sd-rxRNAs targeting connective tissue growth factor for the treatment or prevention of fibrotic disorders)
- AKER +17.9% (received an initial order for the Company's rapid cholesterol self-test from First Check Diagnostics)
- CARA +10.7% (positive top-line results from Part A of its Phase 2/3 trial of I.V. CR845 in chronic kidney disease-associated pruritus )
- OCN +10.6% (entered into 2017 consent order with the New York Department of Financial Services)
- VSTM +7.8% (continued strength)
- TSRO +5.9% (confirms FDA approval of ZEJULA, says implementing plans to initiate registration strategies in the settings of metastatic ovarian, breast and lung cancers)
- AKBA +5.9% (announces the publication of 'positive' results from a Phase 2a study of vadadustat)
- SGBK +5.2% (Stonegate Bank to be acquired by Home BancShares (HOMB) in a $750 mln deal)
- OSIR +3.5% (thinly traded; Osiris Therapeutics completes restatement of 2014 financial statements; also reports preliminary estimated 2015 and 2016 revs)
- ASPS +3.4% (still checking - possibly OCN sympathy)
- TOO +2.9% (in sympathy with other shipping names after multiple upgrades within the space)
- DRYS +2.9% (in sympathy with other shipping names after multiple upgrades within the space)
- CRSP +2.7% (light volume; EPO has announced its intention to grant a patent broadly covering CRISPR's in-licensed gene editing technology)
- TSLA +2% (Tencent Holdings (TCEHY) discloses 5% passive stake)
- DECK +1.8% (3.3% holder Red Mountain calls on Board of Deckers to explore sale of the company)
- SQ +1.2% (launched in the UK)
- RCII +0.9% (adopts stockholder rights plan)
Analyst comments:
- EDIT +15.2% (initiated with a Buy at Chardan Capital Markets; tgt $65)
- SB +13.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- SBLK +8.4% (upgraded to Overweight from Underweight at Morgan Stanley)
- GOGL +6.5% (upgraded to Overweight from Underweight at Morgan Stanley)
- FMSA +4.6% (initiated with Buy ratings at Guggenheim)
- PINC +1.1% (upgraded to Buy from Underperform at BofA/Merrill)